
|Articles|October 15, 2003
Allergan, Syntex involved in patent monopoly case
San Francisco-A federal judge will decide this fall whether a generic formulation of ketorolac tromethamine violates a patent held by Syntex Pharmaceuticals and licensed to Allergan Inc. to make Acular.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























